1. A148: A Multi‐Center, Double‐Blind, Randomized‐Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results. Issue Volume 66:Issue(2014)supplement 3 (March 2014) Authors: Brunner, Hermine; Ruperto, N.; Tzaribachev, N.; Horneff, G.; Wouters, C.; Panaviene, V.; Chasnyk, V.; Abud‐Mendoza, C.; Cuttica, R.; Reiff, A.; Maldonado‐Velázquez, M.; Rubio‐Perez, N.; Alexeeva, Ekaterina; Joos, R.; Keltsev, V.; Nasonov, E.; Kingsbury, D.; Bandeira, M.; Silverman, E.; Weller‐Hei... Journal: Arthritis & rheumatology Issue: Volume 66:Issue(2014)supplement 3 Page Start: S191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A148: A Multi‐Center, Double‐Blind, Randomized‐Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results. Issue 11 (March 2014) Authors: Brunner, Hermine; Ruperto, N.; Tzaribachev, N.; Horneff, G.; Wouters, C.; Panaviene, V.; Chasnyk, V.; Abud‐Mendoza, C.; Cuttica, R.; Reiff, A.; Maldonado‐Velázquez, M.; Rubio‐Perez, N.; Alexeeva, Ekaterina; Joos, R.; Keltsev, V.; Nasonov, E.; Kingsbury, D.; Bandeira, M.; Silverman, E.; Weller‐Hei... Journal: Arthritis & rheumatology Issue: Volume 66:Issue 11(2014)supplement Page Start: S191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0857 Spontaneous Regression of Ebv-Associated Lymphoproliferative Disorder in A Juvenile Idiopathic Arthritis Patient after Discontinuation of Methotrexate and Etanercept. (15th July 2016) Authors: Klein, A.; Reinhard, H.; Mueller, A.; Horneff, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0879 Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Paediatric Patients from Two To Less than Eighteen Years of Age with Juvenile Idiopathic Arthritis. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Hazra, A.; Wang, R.; Mebus, C.; Alvey, C.; Lamba, M.; Krishnaswami, S.; Conte, U.; Wang, M.; Tzaribachev, N.; Foeldvari, I.; Horneff, G.; Kingsbury, D.; Koskova, E.; Smolewska, E.; Vehe, R.K.; Zuber, Z.; Martini, A.; Lovell, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1002 Disease Characteristics and Disease Activity in Enthesitis-Related Arthritis During the First Year of Rheumatology Care – Results from an Inception Cohort Study. (9th June 2015) Authors: Niewerth, M.; Klotsche, J.; Liedmann, I.; Hospach, A.; Horneff, G.; Thon, A.; Huppertz, H.-I.; Kümmerle-Deschner, J.; Sengler, C.; Minden, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB1096 Observational safety study of golimumab in treatment of polyarticular juvenile idiopathic arthritis using the german biologics jia registry. (12th June 2018) Authors: Horneff, G.; Klein, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis. (23rd January 2014) Authors: Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Wulffraat, N.; Horneff, G.; Brik, R.; McCann, L.; Kasapcopur, O.; Rutkowska-Sak, L.; Schneider, R.; Berkun, Y.; Calvo, I.; Erguven, M.; Goffin, L.; Hofer, M.; Kallinich, T.; Knupp, S.; Uziel, Y.; Viola, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study. (23rd January 2014) Authors: Quartier, P.; Erguven, M.; Horneff, G.; Berkun, Y.; Lheritier, K.; Kim, D.; Abrams, K.; Constantin, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB1202 Visualization of remission of arthritis under tnf-inhibition in a patient with juvenile idiopathic arthritis using ICG-enhanced fluorescence optical imaging. (23rd January 2014) Authors: Werner, S.G.; Langer, H.-E.; Backhaus, M.; Horneff, G. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Brief Report: Clinical and Molecular Phenotypes of Low‐Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges. Issue 11 (17th October 2017) Authors: Kuemmerle‐Deschner, J. B.; Verma, D.; Endres, T.; Broderick, L.; de Jesus, A. A.; Hofer, F.; Blank, N.; Krause, K.; Rietschel, C.; Horneff, G.; Aksentijevich, I.; Lohse, P.; Goldbach‐Mansky, R.; Hoffman, H. M.; Benseler, S. M. Journal: Arthritis & rheumatology Issue: Volume 69:Issue 11(2017) Page Start: 2233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗